$239 Million is the total value of First Light Asset Management, LLC's 65 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 57.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Buy | NEOGENOMICS INC | $24,317,000 | +42.8% | 3,089,881 | +4.0% | 10.18% | +21.1% |
| ATRC | Buy | ATRICURE INC | $20,702,000 | +5.1% | 922,557 | +2.6% | 8.67% | -10.9% |
| AKRXQ | Buy | AKORN INC | $12,740,000 | +37.7% | 341,453 | +5.2% | 5.34% | +16.8% |
| ENZ | Buy | ENZO BIOCHEM INC | $10,297,000 | +45.9% | 2,288,292 | +2.8% | 4.31% | +23.7% |
| TLGT | New | TELIGENT INC | $8,888,000 | – | 998,610 | +100.0% | 3.72% | – |
| LHCG | Buy | LHC GROUP INC | $7,345,000 | +7.6% | 162,188 | +6.4% | 3.08% | -8.8% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $7,078,000 | -5.5% | 2,039,753 | +2.9% | 2.96% | -19.9% |
| ELGX | Buy | ENDOLOGIX INC | $6,958,000 | +213.6% | 702,824 | +288.4% | 2.91% | +165.9% |
| ENTL | Buy | ENTELLUS MEDICAL INC | $6,601,000 | +51.1% | 391,497 | +61.4% | 2.76% | +28.1% |
| LMAT | Buy | LEMAITRE VASCULAR INC | $6,587,000 | +43.6% | 381,849 | +1.5% | 2.76% | +21.8% |
| AMED | New | AMEDISYS INC | $5,752,000 | – | 146,287 | +100.0% | 2.41% | – |
| NXTM | Buy | NXSTAGE MEDICAL INC | $5,501,000 | +45.2% | 251,093 | +4.5% | 2.30% | +23.1% |
| LDRH | New | LDR HOLDING CORPORATION | $4,446,000 | – | 177,065 | +100.0% | 1.86% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $4,245,000 | +264.4% | 66,104 | +385.2% | 1.78% | +208.7% |
| MDVN | New | MEDIVATION INC | $4,052,000 | – | 83,816 | +100.0% | 1.70% | – |
| MDCO | Buy | MEDICINES COMPANY | $3,497,000 | +9.5% | 93,656 | +11.4% | 1.46% | -7.1% |
| EVHC | New | ENVISION HEALTHCARE HOLDINGS INC. | $3,459,000 | – | 133,187 | +100.0% | 1.45% | – |
| IMMU | New | IMMUNOMEDICS INC | $2,612,000 | – | 850,757 | +100.0% | 1.09% | – |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $2,452,000 | -14.7% | 1,739,045 | +38.6% | 1.03% | -27.7% |
| PETX | Buy | ARATANA THERAPEUTICS INC | $2,204,000 | +214.4% | 395,043 | +376.5% | 0.92% | +166.8% |
| BIOS | New | BIOSCRIPT INC | $493,000 | – | 281,546 | +100.0% | 0.21% | – |
| A | New | AGILENT TECHNOLOGIES INC | $214,000 | – | 5,120 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-06-10 |
| SC 13G/A | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.